Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (56.155)

61

Efficacy and safety of rademikibart (CBP-201), a next-generation mAb targeting IL-4Rα, in adults with moderate to severe atopic dermatitis : A phase 2 randomized trial (CBP-201-WW001)

enthalten in: The Journal of allergy and clinical immunology | 2024

von Silverberg, J. | Strober, B. | Feinstein, B. | +13

62

Effectiveness and safety of sarilumab in patients with rheumatoid arthritis : A multicenter, retrospective, inverse probability of treatment-weighted analysis based on the FRAB-registry

enthalten in: Clinical rheumatology | 2024

von Harada, H. | Kondo, M. | Maeyama, A. | +8

ErratumIn: Clin Rheumatol. 2024 Mar 15;:. - PMID 38489137

63

Stool Microbiome Signature Associated with Response to Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Cancer

enthalten in: European urology | 2024

von Pederzoli, F. | Riba, M. | Venegoni, C. | +16

CommentIn: Nat Rev Urol. 2024 Feb;21(2):63. - PMID 38228740

64

Zimberelimab combined with systemic therapy extended tumor control in post-radiotherapy cervical cancer with brain metastases : A case report

enthalten in: The journal of obstetrics and gynaecology research | 2024

von Ni, B. | Pan, M. | He, L. | +1

65

Multivalent Rhamnose-Modified EGFR-Targeting Nanobody Gains Enhanced Innate Fc Effector Immunity and Overcomes Cetuximab Resistance via Recruitment of Endogenous Antibodies

enthalten in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) | 2024

von Li, Y. | Lin, H. | Hong, H. | +5

66

Bemarituzumab as first-line treatment for locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma : final analysis of the randomized phase 2 FIGHT trial

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2024

von Wainberg, Z. | Kang, Y. | Lee, K. | +15

67

Obinutuzumab Pretreatment as a Novel Approach to Mitigate Formation of Anti-Drug Antibodies Against Cergutuzumab Amunaleukin in Patients with Solid Tumors

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Peters, S. | Angevin, E. | Alonso-Gordoa, T. | +22

68

Biomarkers Associated with Lung Function Decline and Dupilumab Response in Patients with Asthma

enthalten in: American journal of respiratory and critical care medicine | 2024

von Pavord, I. | De Prado Gómez, L. | Brusselle, G. | +15

69

Baseline eosinophil level may be a predictive indicator for the effectiveness of dupilumab in patients with prurigo nodularis : A single-center, real-world prospective study

enthalten in: Journal of the American Academy of Dermatology | 2024

von Yi, X. | Cao, Q. | Peng, C. | +2

70

Vitreous Opacity Following Intravitreal Brolucizumab Injection : A Case Series Review

enthalten in: Korean journal of ophthalmology : KJO | 2024

von Lee, K. | Lee, S. | Lee, M.